Kayıkçıoğlu, E.; Onder, A. H. . The Pan-Immune-Inflammation-Value Predicts the Survival of Patients With Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors. Chron Precis Med Res 2022, 3.